Bisphosphonate treatment and radiotherapy in metastatic breast cancer.
about
FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients.Bone density as a marker for local response to radiotherapy of spinal bone metastases in women with breast cancer: a retrospective analysis.Symptom management in metastatic breast cancer.Optimal management of bone metastases in breast cancer patients.
P2860
Bisphosphonate treatment and radiotherapy in metastatic breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bisphosphonate treatment and radiotherapy in metastatic breast cancer.
@en
Bisphosphonate treatment and radiotherapy in metastatic breast cancer.
@nl
type
label
Bisphosphonate treatment and radiotherapy in metastatic breast cancer.
@en
Bisphosphonate treatment and radiotherapy in metastatic breast cancer.
@nl
prefLabel
Bisphosphonate treatment and radiotherapy in metastatic breast cancer.
@en
Bisphosphonate treatment and radiotherapy in metastatic breast cancer.
@nl
P2860
P1433
P1476
Bisphosphonate treatment and radiotherapy in metastatic breast cancer.
@en
P2093
A Ugur Ural
Ferit Avcu
P2860
P2888
P304
P356
10.1007/S12032-008-9044-4
P50
P577
2008-01-17T00:00:00Z